Monkey pox: Rethinking COVID‐19 to project future strategies against emerging and evolving pathogens

Abstract

The COVID‐19 pandemic, which spread quickly across the globe toward the end of 2019 and throughout 2020 impacted almost every aspect of daily life [1]. It generated unprecedented uncertainty in the global economy,and disrupted daily routines. Individuals must navigate quarantines, school closing, job insecurity, significantly impairing the physical, mental, social, financial well‐ being of people [2–5]. The impact of the pandemic was more severe than global financial crisis, which was devastating as well to the health and welfare of the human population [6]. The World Health Organization (WHO) on January 30, 2020 announced that the SARS‐CoV‐2 crisis affected all humans globally with countless fatalities, destabilizing the economy order [7]. Preliminary estimates indicate that the total number of global “excess death” attributable to COVID‐19 in 2020 amount to at least 3 million or higher than official figures tracked by the WHO [8, 9].